Saturday 17 October 2026
Export RVTY’s income statement to Excel — free account
Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
152.64
2.07
−1.34%
Follow RVTY
Revvity Inc. (RVTY) SEC filings, changes and red flags
Red flags
-
Officer departure
Revvity Inc. reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Jul 5, 2026 |
P1I2: 8 added · 1 removed · 26 modified P2I1A: 5 modified |
||
| 8-K | Aug 4, 2026 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Apr 5, 2026 | |||
| 8-K | May 5, 2026 | 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 28, 2026 | 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 28, 2025 |
1: 41 added · 15 removed · 74 modified 1A: 4 added · 1 removed · 19 modified 7: 13 added · 32 removed · 18 modified |
||
| 8-K | Feb 2, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 12, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure | ||
| 10-Q | Sep 28, 2025 | |||
| 8-K | Oct 27, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 23, 2025 | 5.02 Departure or appointment of directors or officers | Officer departure | |
| 10-Q | Jun 29, 2025 | |||
| 10-K | Dec 29, 2024 |